The study showed that XPG Asp1104Asp genotype was associated with a decreased risk of developing lung cancer and squamous cell carcinomas of the oropharynx, larynx, and esophagus. Signifying protective effects on these malignancies. This evidence concerns the gene ERCC5 and lung cancer.